Microfold Cells, abbreviated as M cells, are specialized epithelial cells found in the mucosa-associated lymphoid tissues (MALT) of the gastrointestinal tract. These cells play a pivotal role in the immune system by facilitating the transport of antigens and pathogens from the gut lumen to underlying immune cells. M cells possess a unique morphology characterized by a reduced microvilli-covered surface compared to neighboring enterocytes. The primary function of M cells is to sample luminal contents, including bacteria, viruses, and other particles, and present them to immune cells in Peyer's patches and other mucosa-associated lymphoid structures. This process helps initiate immune responses and the development of mucosal immunity. Exploiting M cells is of interest in drug delivery and vaccination strategies. Nanoparticles or antigens can be targeted to M cells to enhance their uptake and subsequent immune response activation. Understanding the molecular and cellular mechanisms governing M cell function is crucial for developing effective mucosal vaccines and therapies for infectious diseases. Research on M cells has revealed their involvement in various intestinal infections, inflammatory bowel diseases, and interactions with commensal microbiota. Ongoing studies continue to unravel the complexities of M cell biology, providing insights into mucosal immunology and potential therapeutic strategies for mucosal-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy